Výsledky vyhledávání - "Maria W Greenwald"

Akademický článek

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

Autor: Mark C. Genovese, Maria W. Greenwald, Sergio R. Gutierrez-Ureña, Mario H. Cardiel, Jeffrey E. Poiley, Anna Zubrzycka-Sienkiewicz, Christine E. Codding, Annie Wang, Weizhong He, Rebecca Amos, Raul Vinueza, Xuegong Wang, Jay P. Garg, Alan J. Kivitz

Publikováno v: Rheumatology and Therapy, Vol 6, Iss 4, Pp 503-520 (2019)

Abstract Introduction Peficitinib is a novel orally bioavailable, once-daily Janus kinase (JAK) inhibitor approved in Japan for the treatment of rheumatoid arthritis (RA). This 2-year extension study of two global phase IIb trials investigated the lo

Externí odkaz: https://doaj.org/article/b2f958b58ad64477b1ce0db746636e51

Zobrazit plný text záznamu

Plný text ve formátu HTML

Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects

Autor: Maria W Greenwald, Viatcheslav Rakov, Eva Lang, Oscar Gluck

Publikováno v: Menopause (New York, N.Y.). 12(6)

Objective A 2-year multicenter, double-blind, randomized, placebo-controlled study examined the efficacy and safety of different doses of 17beta-estradiol (E(2)) alone and continuous-combined oral formulations of E(2) and norethindrone acetate (NETA)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da6102a3266888e2eb055de87e43b7dc
https://pubmed.ncbi.nlm.nih.gov/16278618

Zobrazit plný text záznamu

Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial

Autor: Alan J, Kivitz, Maria W, Greenwald, Stanley B, Cohen, Adam B, Polis, Daryl K, Najarian, Mary E, Dixon, Robert A, Moidel, Jerry A, Green, Herbert S B, Baraf, Richard A, Petruschke, Alan K, Matsumoto, Gregory P, Geba

Publikováno v: Journal of the American Geriatrics Society. 52(5)

To evaluate the use of starting doses of rofecoxib and nabumetone in patients with osteoarthritis (OA) of the knee.A 6-week, randomized, parallel-group, double-blind, placebo-controlled study.One hundred thirteen outpatient sites in the United States

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c67430a8a96025462fe5c73b0dc7b0b5
https://pubmed.ncbi.nlm.nih.gov/15086644

Zobrazit plný text záznamu

Akademický článek

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosusPresented in part at the 64th Annual Scientific Meeting of the American College of Rheumatology, Philadelphia, PA, November 2000, and at the Annual Meeting of the British Society for Rheumatology, Manchester, UK, April 2003.: Results of a multicenter randomized, double?blind, placebo?controlled trial

Publikováno v: Arthritis & Rheumatism; Sep2004, Vol. 50 Issue 9, p2858-2868, 11p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání